These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 32653904)

  • 1. VE-PTP inhibition elicits eNOS phosphorylation to blunt endothelial dysfunction and hypertension in diabetes.
    Siragusa M; Oliveira Justo AF; Malacarne PF; Strano A; Buch A; Withers B; Peters KG; Fleming I
    Cardiovasc Res; 2021 May; 117(6):1546-1556. PubMed ID: 32653904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of vascular endothelial protein tyrosine phosphatase on nitric oxide synthase function in diabetes: from molecular biology to the clinic.
    Justo AFO; Afonso PPL
    J Cell Commun Signal; 2021 Sep; 15(3):467-471. PubMed ID: 33683570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of vascular-endothelial protein tyrosine phosphatase inhibition on breast cancer vasculature and metastatic progression.
    Goel S; Gupta N; Walcott BP; Snuderl M; Kesler CT; Kirkpatrick ND; Heishi T; Huang Y; Martin JD; Ager E; Samuel R; Wang S; Yazbek J; Vakoc BJ; Peterson RT; Padera TP; Duda DG; Fukumura D; Jain RK
    J Natl Cancer Inst; 2013 Aug; 105(16):1188-201. PubMed ID: 23899555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure.
    Symons JD; McMillin SL; Riehle C; Tanner J; Palionyte M; Hillas E; Jones D; Cooksey RC; Birnbaum MJ; McClain DA; Zhang QJ; Gale D; Wilson LJ; Abel ED
    Circ Res; 2009 May; 104(9):1085-94. PubMed ID: 19342603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interfering with VE-PTP stabilizes endothelial junctions in vivo via Tie-2 in the absence of VE-cadherin.
    Frye M; Dierkes M; Küppers V; Vockel M; Tomm J; Zeuschner D; Rossaint J; Zarbock A; Koh GY; Peters K; Nottebaum AF; Vestweber D
    J Exp Med; 2015 Dec; 212(13):2267-87. PubMed ID: 26642851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular Endothelial Receptor Tyrosine Phosphatase: Identification of Novel Substrates Related to Junctions and a Ternary Complex with EPHB4 and TIE2.
    Drexler HCA; Vockel M; Polaschegg C; Frye M; Peters K; Vestweber D
    Mol Cell Proteomics; 2019 Oct; 18(10):2058-2077. PubMed ID: 31427368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-199a-3p and MicroRNA-199a-5p Take Part to a Redundant Network of Regulation of the NOS (NO Synthase)/NO Pathway in the Endothelium.
    Joris V; Gomez EL; Menchi L; Lobysheva I; Di Mauro V; Esfahani H; Condorelli G; Balligand JL; Catalucci D; Dessy C
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2345-2357. PubMed ID: 29976767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature.
    Shen J; Frye M; Lee BL; Reinardy JL; McClung JM; Ding K; Kojima M; Xia H; Seidel C; Lima e Silva R; Dong A; Hackett SF; Wang J; Howard BW; Vestweber D; Kontos CD; Peters KG; Campochiaro PA
    J Clin Invest; 2014 Oct; 124(10):4564-76. PubMed ID: 25180601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The VE-PTP Inhibitor AKB-9778 Improves Antitumor Activity and Diminishes the Toxicity of Interleukin 2 (IL-2) Administration.
    Li G; Sachdev U; Peters K; Liang X; Lotze MT
    J Immunother; 2019 Sep; 42(7):237-243. PubMed ID: 31348125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm's Canal Increasing Outflow Facility and Reducing Intraocular Pressure.
    Li G; Nottebaum AF; Brigell M; Navarro ID; Ipe U; Mishra S; Gomez-Caraballo M; Schmitt H; Soldo B; Pakola S; Withers B; Peters KG; Vestweber D; Stamer WD
    Invest Ophthalmol Vis Sci; 2020 Dec; 61(14):12. PubMed ID: 33315051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of cell spreading and migration by vascular endothelial-protein tyrosine phosphatase (VE-PTP) in cooperation with integrins.
    Mori M; Murata Y; Kotani T; Kusakari S; Ohnishi H; Saito Y; Okazawa H; Ishizuka T; Mori M; Matozaki T
    J Cell Physiol; 2010 Jul; 224(1):195-204. PubMed ID: 20301196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AVE3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats.
    Yang Q; Xue HM; Wong WT; Tian XY; Huang Y; Tsui SK; Ng PK; Wohlfart P; Li H; Xia N; Tobias S; Underwood MJ; He GW
    Br J Pharmacol; 2011 Jul; 163(5):1078-85. PubMed ID: 21385179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the effect of inhibitor AKB-9778 on VE-PTP by molecular docking and molecular dynamics simulation.
    Liu WS; Wang RR; Sun YZ; Li WY; Li HL; Liu CL; Ma Y; Wang RL
    J Cell Biochem; 2019 Oct; 120(10):17015-17029. PubMed ID: 31125141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelium-specific overexpression of human IC53 downregulates endothelial nitric oxide synthase activity and elevates systolic blood pressure in mice.
    Zhuo ML; Huang Y; Chen JZ; Sun LH; Yang RF; Chen HZ; Lv X; Li HL; Wei YS; Liu G; Zhang R; Ma TM; Cai H; Hui RT; Liu DP; Liang CC
    Cardiovasc Res; 2009 Nov; 84(2):292-9. PubMed ID: 19541669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases.
    Di Lorenzo A; Lin MI; Murata T; Landskroner-Eiger S; Schleicher M; Kothiya M; Iwakiri Y; Yu J; Huang PL; Sessa WC
    J Cell Sci; 2013 Dec; 126(Pt 24):5541-52. PubMed ID: 24046447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathionylation mediates angiotensin II-induced eNOS uncoupling, amplifying NADPH oxidase-dependent endothelial dysfunction.
    Galougahi KK; Liu CC; Gentile C; Kok C; Nunez A; Garcia A; Fry NA; Davies MJ; Hawkins CL; Rasmussen HH; Figtree GA
    J Am Heart Assoc; 2014 Apr; 3(2):e000731. PubMed ID: 24755153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of NAD(P)H:quinone oxidoreductase ameliorates spontaneous hypertension in an animal model via modulation of eNOS activity.
    Kim YH; Hwang JH; Noh JR; Gang GT; Kim DH; Son HY; Kwak TH; Shong M; Lee IK; Lee CH
    Cardiovasc Res; 2011 Aug; 91(3):519-27. PubMed ID: 21502369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation.
    Hayashi M; Majumdar A; Li X; Adler J; Sun Z; Vertuani S; Hellberg C; Mellberg S; Koch S; Dimberg A; Koh GY; Dejana E; Belting HG; Affolter M; Thurston G; Holmgren L; Vestweber D; Claesson-Welsh L
    Nat Commun; 2013; 4():1672. PubMed ID: 23575676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of telmisartan reduced systolic blood pressure and oxidative stress probably through the activation of PI3K/Akt/eNOS pathway and NO release in spontaneously hypertensive rats.
    Xu L; Liu Y
    Physiol Res; 2013; 62(4):351-9. PubMed ID: 23590610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial nitric oxide synthase enhancer reduces oxidative stress and restores endothelial function in db/db mice.
    Cheang WS; Wong WT; Tian XY; Yang Q; Lee HK; He GW; Yao X; Huang Y
    Cardiovasc Res; 2011 Nov; 92(2):267-75. PubMed ID: 21875904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.